https://www.thebodypro.com/article/actg-5095-efavirenz-based-regimens-outperform-triple-nucleoside-c
Abacavir/Lamivudine/Zidovudine (Trizivir)

ACTG 5095: Efavirenz-Based Regimens Outperform Triple Nucleoside Combination

    Brian A. Boyle, M.D., J.D.